The Danish-based leader in augmented pathology solutions Visiopharm has secured a grant worth £250,000 from UK Research and Innovation to test its innovative solutions in partnership with the NHS. The grant, offered by the UK Government’s...

Courtesy of IBEX Cancer is a leading cause of death globally and one of the main challenges modern healthcare is facing. According to the World Health Organization, the number of new cancer cases is expected to grow by 70% over the next two...

When: Wed, Jun 6, 2018 10:00 AM - 11:00 AM PDT Register Now   PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in determining...